Paul Goode

Insider Reports History

Location
St. Louis, MO
Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Goode:

Company Role Class Num Shares Value Price $ Report Date Ownership
Glucotrack, Inc. Chief Executive Officer, Director Common Stock, par value $0.001 per share 339 $1,650 $4.87 25 Mar 2025 Direct
GlucoTrack, Inc. Chief Executive Officer, Director Stock option (right to buy) 3,277 14 Jun 2024 Direct
GlucoTrack, Inc. Chief Executive Officer, Director Warrants to Purchase Common Stock 2,100 01 Jul 2024 Direct
GlucoTrack, Inc. Chief Executive Officer, Director Series A Common Warrant 796 14 Nov 2024 Direct
GlucoTrack, Inc. Chief Executive Officer, Director Series B Common Warrant 0 12 Mar 2025 Direct
GlucoTrack, Inc. Chief Executive Officer, Director Convertible Promissory Note $0 14 Nov 2024 Direct

Insider Reports Filed by Paul Goode

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GCTK Glucotrack, Inc. 25 Mar 2025 1 $0 4 Chief Executive Officer, Director 07 Oct 2025, 19:26
GCTK GlucoTrack, Inc. 01 Jul 2024 1 $0 4 Chief Executive Officer 03 Jul 2024, 17:26
GCTK Glucotrack, Inc. 14 Jun 2024 10 +$10,004 4 Chief Executive Officer, Director 28 Mar 2025, 21:43
GCTK GlucoTrack, Inc. 22 Apr 2024 0 $0 3 Chief Executive Officer 24 Apr 2024, 21:00